Content related to CHLA Researcher to Lead First-Ever International Liquid Biopsy Retinoblastoma Study

International retinoblastoma research study to begin this summer to investigate liquid biopsy and its use in diagnosing and determining disease severity in retinoblastoma.

The ambitions of pediatric researchers are global in scale: Beyond patients at their own hospital, they look to shape national and international standards for pediatric care.

Children’s Hospital Los Angeles researchers develop a pediatric solid tumor liquid biopsy for use when obtaining a tissue biopsy is not feasible.

CHLA has been at the forefront of retinoblastoma research for decades. Cobrinik was invited to review the current state of retinoblastoma research.

The Summer Oncology Research Fellowship (SORF) at Children’s Hospital Los Angeles and USC encourages medical students from around the nation to pursue research.

A Children’s Hospital Los Angeles team is studying COVID-19’s potential impact on beta cells and developing an algorithm to predict risk for long COVID.

Experts at Children’s Hospital Los Angeles and USC share how spatially fractionated radiation therapy and VMAT are enhancing radiation treatment for kids.

After her son was diagnosed with a rare tumor, Melissa searched for help. She found it at CHLA in the office of Dr. Ashley Margol, one of the few experts in an innovative therapy called MEMMAT.

A CHLA oncologist is leading new research to improve outcomes for children, adolescents and young adults with relapsed or treatment-resistant germ cell tumors.